Murdoch University Research Repository

Welcome to the Murdoch University Research Repository

The Murdoch University Research Repository is an open access digital collection of research
created by Murdoch University staff, researchers and postgraduate students.

Learn more

Lactoferrin expression is not associated with Late-Onset sepsis in very preterm infants

Strunk, T., Hibbert, J.E., Doherty, D., Nathan, E., Simmer, K., Patole, S.K., Trend, S., Richmond, P., Burgner, D. and Currie, A. (2020) Lactoferrin expression is not associated with Late-Onset sepsis in very preterm infants. Neonatology . pp. 1-6.

Link to Published Version: https://doi.org/10.1159/000509404
*Subscription may be required

Abstract

Background: Preterm infants are at a high risk of developing late-onset sepsis (LOS). Lactoferrin is one of the most abundant endogenous antimicrobial proteins expressed in breast milk, stools, and blood, and a candidate for preventive intervention. Large clinical trials have recently investigated whether enteral supplementation with bovine lactoferrin reduces LOS. Aim: To characterize lactoferrin levels in preterm infants with and without LOS during the first month of life. Methods: Very preterm and term infants were recruited and serial biosamples collected during the first month of life. Lactoferrin levels were determined by immunoassay in cord blood and peripheral blood on days 1, 7, 14, 21, and 28; in the stools on days 1 and 28; and in the mother’s breast milk on days 7 and 21. Furthermore, we assessed the capacity of the peripheral blood to release lactoferrin in response to an in vitro challenge with live Staphylococcus epidermidis, lipopolysaccharide, and fibroblast-stimulating lipopeptide 1. Results: Plasma lactoferrin levels were higher in cord blood and day 1 peripheral blood and declined during the first month of life. Plasma lactoferrin levels were similar in term infants and in preterm infants with (n = 32) and without LOS (n = 53). S. epidermidis-induced lactoferrin levels were lower following the sepsis episode. Conclusions: Endogenous lactoferrin expression in preterm infants does not appear to affect their risk of developing LOS. These findings are in line with the lack of benefit recently observed in large trials of enteral supplementation with bovine lactoferrin to prevent LOS.

Item Type: Journal Article
Murdoch Affiliation: Medical, Molecular and Forensic Sciences
Publisher: Karger AS
Copyright: © 2020 S. Karger AG, Basel
URI: http://researchrepository.murdoch.edu.au/id/eprint/57930
Item Control Page Item Control Page